A conference call will be held today, Wednesday, October 22, 5:00 p.m. E.D.T. DUSA Pharmaceuticals, Inc.® (NASDAQ GM: DUSA) announced today results from its Phase IIB clinical trial to compare the ...

The MarketWatch News Department was not involved in the creation of this content. Acquiring the Canadian rights to LEVULAN KERASTICK (aminolevulinic acid hydrochloride) further expands the Sun Pharma ...

Wilmington-based DUSA Pharmaceuticals recently conducted a study on Levulan Photodynamic Therapy (PDT) for patients with squamous cell carcinomas (SCCs). The study, conducted by researchers at the ...

The downturn has been particularly cruel to laser dermatology companies, which often rely on nonessential treatments that patients must pay for out of pocket. Companies with laser treatments for acne, ...

The downturn has been particularly cruel to laser dermatology companies, which often rely on nonessential treatments that patients must pay for out of pocket. Companies with laser treatments for acne, ...

SAN FRANCISCO (MarketWatch) -- Dusa Pharmaceuticals Inc. shares leapt 35% to $3.75 in Thursday morning trade. The Wilmington, Mass.-based company announced that the Food and Drug Administration has ...

With new restrictions on prescribing Accutane and other forms of isotretinoin now in effect, light and heat treatments for pimples may become more popular, doctors say. Although they cannot banish ...

Q1 Domestic Kerastick ® Revenues Up 35% Year-Over-Year; Domestic PDT Revenues Up 33% Conference Call and Audio Webcast Will be Held Today, May 5 th, at 8:30 am EDT WILMINGTON, Mass., May 5, 2011 ...

June 1, 2007 — The US Food and Drug Administration (FDA) has granted orphan drug designation for aminolevulinic acid HCl in combination with photodynamic therapy for the treatment of esophageal ...

LEVULAN KERASTICK for topical solution, 20%, plus blue light illumination using the BLU-U Blue Light Photodynamic Therapy Illuminator is used to treat minimally to moderately thick actinic keratoses ...

LEVULAN KERASTICK offers patients and health care practitioners a treatment option with a well-established safety and efficacy profile that can prevent the progression of actinic keratoses into skin ...